Covered recipient · General Payments record
JEROME B BLUMENTHAL
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2020
$505.57
- Reported across 31 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2020 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $176.92 | 11 |
By paying entity
PY2020 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Insulet Corporation | $60.46 | 3 |
| Novo Nordisk AS | $31.02 | 2 |
| ABBVIE INC. | $27.59 | 2 |
| Acerta Pharma LLC | $17.32 | 1 |
| Radius Health, Inc. | $15.51 | 1 |
| Merck Sharp & Dohme Corporation | $13.45 | 1 |
| Antares Pharma, Inc. | $11.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2020 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $11.34 | 07/13/2020 | Food and Beverage | Undisputed | 01/23/2026 | 721702373 | CMS |
| AbbVie Inc. | $16.25 | 08/18/2020 | Food and Beverage | Undisputed | 01/23/2026 | 721702375 | CMS |
| Antares Pharma, Inc. | $11.57 | 07/02/2020 | Food and Beverage | Undisputed | 01/23/2026 | 751418435 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.32 | 09/24/2020 | Food and Beverage | Undisputed | 01/23/2026 | 735854713 | CMS |
| Insulet Corporation | $25.60 | 01/22/2020 | Food and Beverage | Undisputed | 01/23/2026 | 748416205 | CMS |
| Insulet Corporation | $23.16 | 02/25/2020 | Food and Beverage | Undisputed | 01/23/2026 | 748416201 | CMS |
| Insulet Corporation | $11.70 | 05/15/2020 | Food and Beverage | Undisputed | 01/23/2026 | 748420227 | CMS |
| Merck Sharp & Dohme Corporation | $13.45 | 07/21/2020 | Food and Beverage | Undisputed | 01/23/2026 | 747649149 | CMS |
| Novo Nordisk Inc | $12.10 | 04/21/2020 | Food and Beverage | Undisputed | 01/23/2026 | 744668615 | CMS |
| Novo Nordisk Inc | $18.92 | 10/07/2020 | Food and Beverage | Undisputed | 01/23/2026 | 744918091 | CMS |
| Radius Health, Inc. | $15.51 | 06/01/2020 | Food and Beverage | Undisputed | 01/23/2026 | 746274125 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020
- Generated from
- OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.